Bhang Inc.
Bhang Inc.
Your view on BHNGF
Overview
What the company does, where it operates, and who runs it.
About Bhang Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- John Graham Simmonds Jr.
- Headquarters
- 40 King Street West, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- John Graham Simmonds Jr.
- Headquarters
- 40 King Street West, Toronto, ON, CA
Bhang Inc. operates as a cannabis consumer packaged goods brand company in the United States. Its portfolio of products include cannabis; hempderived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies.
The company also provides milk chocolate, ice milk chocolate, caramel mocha milk chocolate, cherries and cream milk chocolate, caramel dark chocolate, dark chocolate, fire dark chocolate, blueberry dark chocolate, fried chicken and cola dark chocolate, toffee and salt dark chocolate, italian espresso dark chocolate, cookies and cream white chocolate, and white toast white chocolate bar; and infused joints, such as fig bars.
In addition, it produces and distributes cannabis-infused products through partners and licensees that are distributed worldwide. Bhang Inc. is based in Toronto, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Bhang Inc., and the rating behind it. BHNGF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Bhang Inc.. Starting points for Bhang Inc.: EPS -$0.02, beta 2.38 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Bhang Inc.. Bhang Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Bhang Inc.. Trailing twelve-month EPS for Bhang Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Bhang Inc.. Bhang Inc. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Bhang Inc. valued side by side against its closest peers. Bhang Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Bhang Inc., and how their positions are changing. At a $23,476 market value, institutional positions materially move Bhang Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Bhang Inc. executives and directors. Shares of Bhang Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Bhang Inc.. Bhang Inc. is a $23,476 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Bhang Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Bhang Inc.. Coverage tracks Bhang Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.